{"id":5116,"date":"2024-04-17T00:08:03","date_gmt":"2024-04-17T04:08:03","guid":{"rendered":"https:\/\/colpittsclinical.com\/?p=5116"},"modified":"2024-04-21T23:52:52","modified_gmt":"2024-04-22T03:52:52","slug":"supporting-patients-with-fabry-disease-in-clinical-trials","status":"publish","type":"post","link":"https:\/\/colpittsclinical.com\/hu\/supporting-patients-with-fabry-disease-in-clinical-trials\/","title":{"rendered":"A Fabry-k\u00f3ros betegek t\u00e1mogat\u00e1sa a klinikai vizsg\u00e1latokban"},"content":{"rendered":"

A szakad\u00e9k \u00e1thidal\u00e1sa: a Fabry-k\u00f3ros betegek t\u00e1mogat\u00e1sa a klinikai vizsg\u00e1latokon kereszt\u00fcl<\/b><\/h2>\n

\u00c1prilis a Fabry-k\u00f3rral kapcsolatos figyelemfelkelt\u00e9s h\u00f3napja, amely egy ritka genetikai rendelleness\u00e9g, amely vil\u00e1gszerte t\u00f6bb ezer embert \u00e9rint. A Colpitts Clinicaln\u00e9l felismert\u00fck annak fontoss\u00e1g\u00e1t, hogy t\u00e1mogassuk az olyan ritka betegs\u00e9gekben szenved\u0151 betegeket, mint a Fabry-k\u00f3r, \u00e9s biztos\u00edtsuk sz\u00e1mukra a klinikai vizsg\u00e1latokon kereszt\u00fcl a legmodernebb kezel\u00e9sekhez val\u00f3 hozz\u00e1f\u00e9r\u00e9st. Ebben a bejegyz\u00e9sben a Fabry-k\u00f3r tudatoss\u00e1gi h\u00f3nap jelent\u0151s\u00e9g\u00e9t vizsg\u00e1ljuk meg, \u00e9s azt, hogy a Colpitts Clinical milyen fontos szerepet j\u00e1tszik a betegek \u00e9s a sz\u00e1mukra el\u00e9rhet\u0151 kezel\u00e9sek k\u00f6z\u00f6tti szakad\u00e9k \u00e1thidal\u00e1s\u00e1ban.<\/p>\n

A Fabry-k\u00f3r meg\u00e9rt\u00e9se:<\/i><\/strong><\/p>\n

A Fabry-k\u00f3r egy ritka genetikai rendelleness\u00e9g, amelyet az alfa-galaktozid\u00e1z A (\u03b1-Gal A) nev\u0171 enzim hi\u00e1nya okoz. Ez az enzimhi\u00e1ny bizonyos zs\u00edrok, els\u0151sorban globotriaozilceramid (Gb3) felhalmoz\u00f3d\u00e1s\u00e1hoz vezet a szervezet k\u00fcl\u00f6nb\u00f6z\u0151 sejtjeiben. Id\u0151vel ez a felhalmoz\u00f3d\u00e1s a t\u00fcnetek sz\u00e9les sk\u00e1l\u00e1j\u00e1t eredm\u00e9nyezheti, bele\u00e9rtve a f\u00e1jdalmat, a vesem\u0171k\u00f6d\u00e9si zavarokat, sz\u00edvkomplik\u00e1ci\u00f3kat \u00e9s neurol\u00f3giai probl\u00e9m\u00e1kat. Annak ellen\u00e9re, hogy ritka betegs\u00e9gr\u0151l van sz\u00f3, a Fabry jelent\u0151s hat\u00e1ssal lehet a betegek \u00e9let\u00e9re, befoly\u00e1solva \u00e9letmin\u0151s\u00e9g\u00fcket \u00e9s \u00e1ltal\u00e1nos eg\u00e9szs\u00e9gi \u00e1llapotukat.<\/p>\n

Colpitts Clinical szerepe:<\/i><\/strong><\/p>\n

A Colpitts Clinicaln\u00e9l meg\u00e9rtj\u00fck a ritka betegs\u00e9gekben szenved\u0151 betegek el\u0151tt \u00e1ll\u00f3 kih\u00edv\u00e1sokat, bele\u00e9rtve a speci\u00e1lis ell\u00e1t\u00e1shoz val\u00f3 hozz\u00e1f\u00e9r\u00e9st \u00e9s a klinikai vizsg\u00e1latokban val\u00f3 r\u00e9szv\u00e9telt. Ez\u00e9rt elk\u00f6telezettek vagyunk amellett, hogy \u00e1thidaljuk a betegek \u00e9s a sz\u00e1mukra el\u00e9rhet\u0151 kezel\u00e9sek k\u00f6z\u00f6tti szakad\u00e9kot. Csapatunk szorosan egy\u00fcttm\u0171k\u00f6dik a k\u00eds\u00e9rleti szponzorokkal, kutat\u00f3int\u00e9zetekkel \u00e9s CRO-kkal a Fabry-k\u00f3r \u00e9s m\u00e1s ritka betegs\u00e9gek klinikai vizsg\u00e1latainak megk\u00f6nny\u00edt\u00e9se \u00e9rdek\u00e9ben.<\/p>\n

\u00c1tfog\u00f3 t\u00e1mogat\u00f3 szolg\u00e1ltat\u00e1saink c\u00e9lja, hogy a betegek sz\u00e1m\u00e1ra a lehet\u0151 legz\u00f6kken\u0151mentesebb\u00e9 tegy\u00fck a klinikai vizsg\u00e1latot. Az oktat\u00e1st\u00f3l \u00e9s tan\u00e1csad\u00e1st\u00f3l kezdve az utaz\u00e1s \u00e9s a logisztika koordin\u00e1l\u00e1s\u00e1ig igyeksz\u00fcnk enyh\u00edteni a kutat\u00e1si vizsg\u00e1latokban val\u00f3 r\u00e9szv\u00e9tellel gyakran j\u00e1r\u00f3 terheket. Ezen t\u00falmen\u0151en a vizsg\u00e1lat sor\u00e1n a betegek biztons\u00e1g\u00e1t \u00e9s j\u00f3l\u00e9t\u00e9t helyezz\u00fck el\u0151t\u00e9rbe, biztos\u00edtva, hogy a r\u00e9sztvev\u0151k a legmagasabb sz\u00ednvonal\u00fa ell\u00e1t\u00e1sban r\u00e9szes\u00fcljenek.<\/p>\n

Hogyan seg\u00edthet?<\/i><\/strong><\/p>\n

Vegyen r\u00e9szt:<\/b>\u00a0A Fabry-k\u00f3r tudatoss\u00e1gi h\u00f3napja alatt \u00e9s azon t\u00fal is sz\u00e1mos m\u00f3don lehet r\u00e9szt venni a Fabry-k\u00f3rral \u00e9l\u0151 egy\u00e9nek t\u00e1mogat\u00e1s\u00e1ban:<\/p>\n

N\u00f6velje a tudatoss\u00e1got:<\/b>\u00a0Osszon meg inform\u00e1ci\u00f3kat a Fabry-k\u00f3rr\u00f3l a k\u00f6z\u00f6ss\u00e9gi m\u00e9di\u00e1ban, szervezzen figyelemfelkelt\u0151 rendezv\u00e9nyeket, vagy vegyen r\u00e9szt helyi \u00e9rdek\u00e9rv\u00e9nyes\u00edt\u0151 tev\u00e9kenys\u00e9gekben.<\/p>\n

Kutat\u00e1s t\u00e1mogat\u00e1sa:<\/b>\u00a0Fontolja meg az adom\u00e1nyoz\u00e1st a Fabry-k\u00f3r kutat\u00e1s\u00e1nak finansz\u00edroz\u00e1s\u00e1val foglalkoz\u00f3 szervezeteknek, vagy vegyen r\u00e9szt \u00f6nk\u00e9ntesk\u00e9nt klinikai vizsg\u00e1latokban, ha jogosult r\u00e1.<\/p>\n

A hozz\u00e1f\u00e9r\u00e9s\u00e9rt val\u00f3 ki\u00e1ll\u00e1s:<\/b>\u00a0Olyan szakpolitik\u00e1k\u00e9rt val\u00f3 ki\u00e1ll\u00e1s, amelyek biztos\u00edtj\u00e1k a ritka betegs\u00e9gekben szenved\u0151 egy\u00e9nek sz\u00e1m\u00e1ra a megfizethet\u0151 kezel\u00e9sekhez \u00e9s t\u00e1mogat\u00f3 szolg\u00e1ltat\u00e1sokhoz val\u00f3 hozz\u00e1f\u00e9r\u00e9st.<\/p>\n

Egy\u00fctt v\u00e1ltoztathatunk a Fabry-k\u00f3rban \u00e9s m\u00e1s ritka betegs\u00e9gekben szenved\u0151 betegek \u00e9let\u00e9n.<\/p>\n

A Fabry-betegs\u00e9ggel kapcsolatos figyelemfelkelt\u0151 h\u00f3nap eml\u00e9keztet a ritka betegs\u00e9gekkel \u00e9l\u0151 egy\u00e9nek t\u00e1mogat\u00e1s\u00e1nak fontoss\u00e1g\u00e1ra \u00e9s a hat\u00e9kony kezel\u00e9sek megtal\u00e1l\u00e1s\u00e1t c\u00e9lz\u00f3 kutat\u00e1si er\u0151fesz\u00edt\u00e9sek el\u0151mozd\u00edt\u00e1s\u00e1ra. A Colpitts Clinicaln\u00e9l elk\u00f6telezettek vagyunk amellett, hogy \u00e1tfog\u00f3 t\u00e1mogat\u00f3 szolg\u00e1ltat\u00e1saink r\u00e9v\u00e9n t\u00e1mogassuk a Fabry-k\u00f3rban szenved\u0151 betegeket, \u00e9s klinikai vizsg\u00e1latokon kereszt\u00fcl megk\u00f6nny\u00edts\u00fck az innovat\u00edv ter\u00e1pi\u00e1khoz val\u00f3 hozz\u00e1f\u00e9r\u00e9st. Egy\u00fcttm\u0171k\u00f6d\u00e9s\u00fcnkkel l\u00e9p\u00e9seket tehet\u00fcnk a Fabry-k\u00f3rban \u00e9s m\u00e1s ritka betegs\u00e9gekben szenved\u0151k \u00e9let\u00e9nek jav\u00edt\u00e1sa fel\u00e9. Csatlakozzon hozz\u00e1nk a figyelemfelkelt\u00e9sben, a kutat\u00e1sok t\u00e1mogat\u00e1s\u00e1ban \u00e9s az ell\u00e1t\u00e1shoz val\u00f3 hozz\u00e1f\u00e9r\u00e9s\u00e9rt val\u00f3 ki\u00e1ll\u00e1sban. Egy\u00fctt \u00e1thidalhatjuk a szakad\u00e9kot, \u00e9s rem\u00e9nyt adhatunk a betegeknek \u00e9s csal\u00e1djaiknak.<\/p>\n

 <\/p>\n

Tov\u00e1bbi inform\u00e1ci\u00f3 a klinikai vizsg\u00e1latokr\u00f3l<\/strong><\/em><\/p>\n

Hogyan \u00e9p\u00edtik ki az utaz\u00e1si szolg\u00e1ltat\u00e1sok a jobb klinikai vizsg\u00e1latok utaz\u00e1si \u00e9lm\u00e9ny\u00e9t?<\/a><\/p>\n

A klinikai vizsg\u00e1latok \u00e9s a t\u00e1mogat\u00f3 utaz\u00e1si koordin\u00e1ci\u00f3 l\u00e9tfontoss\u00e1g\u00fa szerepe<\/a><\/p>\n

Lehet\u0151v\u00e9 t\u00e9ve a lehetetlent<\/a><\/p>\n

L\u00e1togasson el hozz\u00e1nk a\u00a0Facebook<\/a><\/p>","protected":false},"excerpt":{"rendered":"

Bridging the Gap: Supporting Patients with Fabry Disease Through Clinical Trials April is a month dedicated to raising awareness about Fabry Disease, a rare genetic disorder that affects thousands of individuals worldwide. At Colpitts Clinical, we recognize the importance of supporting patients living with rare diseases like Fabry and ensuring they have access to cutting-edge […]<\/p>\n","protected":false},"author":1,"featured_media":5132,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[6,30],"tags":[],"class_list":["post-5116","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-clinical-trials","category-rare-diseases"],"yoast_head":"\nSupporting Patients with Fabry Disease in Clinical Trials - Colpitts Clinical<\/title>\n<meta name=\"description\" content=\"April is a month dedicated to raising awareness about Fabry Disease, a rare genetic disorder that affects thousands of individuals worldwide.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/colpittsclinical.com\/hu\/supporting-patients-with-fabry-disease-in-clinical-trials\/\" \/>\n<meta property=\"og:locale\" content=\"hu_HU\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Supporting Patients with Fabry Disease in Clinical Trials - Colpitts Clinical\" \/>\n<meta property=\"og:description\" content=\"April is a month dedicated to raising awareness about Fabry Disease, a rare genetic disorder that affects thousands of individuals worldwide.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/colpittsclinical.com\/hu\/supporting-patients-with-fabry-disease-in-clinical-trials\/\" \/>\n<meta property=\"og:site_name\" content=\"Colpitts Clinical\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ColpittsClinicalTrialTravel\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-04-17T04:08:03+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-04-22T03:52:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/colpittsclinical.com\/wp-content\/uploads\/2024\/04\/fabry_disease.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"828\" \/>\n\t<meta property=\"og:image:height\" content=\"420\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"clinical\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Szerz\u0151:\" \/>\n\t<meta name=\"twitter:data1\" content=\"clinical\" \/>\n\t<meta name=\"twitter:label2\" content=\"Becs\u00fclt olvas\u00e1si id\u0151\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 perc\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/supporting-patients-with-fabry-disease-in-clinical-trials\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/supporting-patients-with-fabry-disease-in-clinical-trials\\\/\"},\"author\":{\"name\":\"clinical\",\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/#\\\/schema\\\/person\\\/7f5c1f500aa2df676ac51a2c6236e2fd\"},\"headline\":\"Supporting Patients with Fabry Disease in Clinical Trials\",\"datePublished\":\"2024-04-17T04:08:03+00:00\",\"dateModified\":\"2024-04-22T03:52:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/supporting-patients-with-fabry-disease-in-clinical-trials\\\/\"},\"wordCount\":542,\"publisher\":{\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/supporting-patients-with-fabry-disease-in-clinical-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/colpittsclinical.com\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/fabry_disease.jpg?fit=828%2C420&ssl=1\",\"articleSection\":[\"Clinical Trials\",\"Rare Diseases\"],\"inLanguage\":\"hu\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/supporting-patients-with-fabry-disease-in-clinical-trials\\\/\",\"url\":\"https:\\\/\\\/colpittsclinical.com\\\/supporting-patients-with-fabry-disease-in-clinical-trials\\\/\",\"name\":\"Supporting Patients with Fabry Disease in Clinical Trials - Colpitts Clinical\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/supporting-patients-with-fabry-disease-in-clinical-trials\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/supporting-patients-with-fabry-disease-in-clinical-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/colpittsclinical.com\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/fabry_disease.jpg?fit=828%2C420&ssl=1\",\"datePublished\":\"2024-04-17T04:08:03+00:00\",\"dateModified\":\"2024-04-22T03:52:52+00:00\",\"description\":\"April is a month dedicated to raising awareness about Fabry Disease, a rare genetic disorder that affects thousands of individuals worldwide.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/supporting-patients-with-fabry-disease-in-clinical-trials\\\/#breadcrumb\"},\"inLanguage\":\"hu\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/colpittsclinical.com\\\/supporting-patients-with-fabry-disease-in-clinical-trials\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"hu\",\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/supporting-patients-with-fabry-disease-in-clinical-trials\\\/#primaryimage\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/colpittsclinical.com\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/fabry_disease.jpg?fit=828%2C420&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/colpittsclinical.com\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/fabry_disease.jpg?fit=828%2C420&ssl=1\",\"width\":828,\"height\":420,\"caption\":\"Supporting patients with Fabry disease\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/supporting-patients-with-fabry-disease-in-clinical-trials\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/colpittsclinical.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Supporting Patients with Fabry Disease in Clinical Trials\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/#website\",\"url\":\"https:\\\/\\\/colpittsclinical.com\\\/\",\"name\":\"Colpitts Clinical\",\"description\":\"patient-liaison\",\"publisher\":{\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/colpittsclinical.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"hu\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/#organization\",\"name\":\"Colpitts Clinical\",\"url\":\"https:\\\/\\\/colpittsclinical.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"hu\",\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/colpittsclinical.com\\\/wp-content\\\/uploads\\\/2017\\\/10\\\/cc-logo-212-1.png\",\"contentUrl\":\"https:\\\/\\\/colpittsclinical.com\\\/wp-content\\\/uploads\\\/2017\\\/10\\\/cc-logo-212-1.png\",\"width\":212,\"height\":48,\"caption\":\"Colpitts Clinical\"},\"image\":{\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ColpittsClinicalTrialTravel\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/colpittsclinical\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/#\\\/schema\\\/person\\\/7f5c1f500aa2df676ac51a2c6236e2fd\",\"name\":\"clinical\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"hu\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b87dd30974d276d493a32a1592debd029f0e03dcf67fc5da941cf694874d67de?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b87dd30974d276d493a32a1592debd029f0e03dcf67fc5da941cf694874d67de?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b87dd30974d276d493a32a1592debd029f0e03dcf67fc5da941cf694874d67de?s=96&d=mm&r=g\",\"caption\":\"clinical\"},\"url\":\"https:\\\/\\\/colpittsclinical.com\\\/hu\\\/author\\\/cclinical\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Supporting Patients with Fabry Disease in Clinical Trials - Colpitts Clinical","description":"April is a month dedicated to raising awareness about Fabry Disease, a rare genetic disorder that affects thousands of individuals worldwide.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/colpittsclinical.com\/hu\/supporting-patients-with-fabry-disease-in-clinical-trials\/","og_locale":"hu_HU","og_type":"article","og_title":"Supporting Patients with Fabry Disease in Clinical Trials - Colpitts Clinical","og_description":"April is a month dedicated to raising awareness about Fabry Disease, a rare genetic disorder that affects thousands of individuals worldwide.","og_url":"https:\/\/colpittsclinical.com\/hu\/supporting-patients-with-fabry-disease-in-clinical-trials\/","og_site_name":"Colpitts Clinical","article_publisher":"https:\/\/www.facebook.com\/ColpittsClinicalTrialTravel\/","article_published_time":"2024-04-17T04:08:03+00:00","article_modified_time":"2024-04-22T03:52:52+00:00","og_image":[{"width":828,"height":420,"url":"https:\/\/colpittsclinical.com\/wp-content\/uploads\/2024\/04\/fabry_disease.jpg","type":"image\/jpeg"}],"author":"clinical","twitter_card":"summary_large_image","twitter_misc":{"Szerz\u0151:":"clinical","Becs\u00fclt olvas\u00e1si id\u0151":"3 perc"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/colpittsclinical.com\/supporting-patients-with-fabry-disease-in-clinical-trials\/#article","isPartOf":{"@id":"https:\/\/colpittsclinical.com\/supporting-patients-with-fabry-disease-in-clinical-trials\/"},"author":{"name":"clinical","@id":"https:\/\/colpittsclinical.com\/#\/schema\/person\/7f5c1f500aa2df676ac51a2c6236e2fd"},"headline":"Supporting Patients with Fabry Disease in Clinical Trials","datePublished":"2024-04-17T04:08:03+00:00","dateModified":"2024-04-22T03:52:52+00:00","mainEntityOfPage":{"@id":"https:\/\/colpittsclinical.com\/supporting-patients-with-fabry-disease-in-clinical-trials\/"},"wordCount":542,"publisher":{"@id":"https:\/\/colpittsclinical.com\/#organization"},"image":{"@id":"https:\/\/colpittsclinical.com\/supporting-patients-with-fabry-disease-in-clinical-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/colpittsclinical.com\/wp-content\/uploads\/2024\/04\/fabry_disease.jpg?fit=828%2C420&ssl=1","articleSection":["Clinical Trials","Rare Diseases"],"inLanguage":"hu"},{"@type":"WebPage","@id":"https:\/\/colpittsclinical.com\/supporting-patients-with-fabry-disease-in-clinical-trials\/","url":"https:\/\/colpittsclinical.com\/supporting-patients-with-fabry-disease-in-clinical-trials\/","name":"Supporting Patients with Fabry Disease in Clinical Trials - Colpitts Clinical","isPartOf":{"@id":"https:\/\/colpittsclinical.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/colpittsclinical.com\/supporting-patients-with-fabry-disease-in-clinical-trials\/#primaryimage"},"image":{"@id":"https:\/\/colpittsclinical.com\/supporting-patients-with-fabry-disease-in-clinical-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/colpittsclinical.com\/wp-content\/uploads\/2024\/04\/fabry_disease.jpg?fit=828%2C420&ssl=1","datePublished":"2024-04-17T04:08:03+00:00","dateModified":"2024-04-22T03:52:52+00:00","description":"April is a month dedicated to raising awareness about Fabry Disease, a rare genetic disorder that affects thousands of individuals worldwide.","breadcrumb":{"@id":"https:\/\/colpittsclinical.com\/supporting-patients-with-fabry-disease-in-clinical-trials\/#breadcrumb"},"inLanguage":"hu","potentialAction":[{"@type":"ReadAction","target":["https:\/\/colpittsclinical.com\/supporting-patients-with-fabry-disease-in-clinical-trials\/"]}]},{"@type":"ImageObject","inLanguage":"hu","@id":"https:\/\/colpittsclinical.com\/supporting-patients-with-fabry-disease-in-clinical-trials\/#primaryimage","url":"https:\/\/i0.wp.com\/colpittsclinical.com\/wp-content\/uploads\/2024\/04\/fabry_disease.jpg?fit=828%2C420&ssl=1","contentUrl":"https:\/\/i0.wp.com\/colpittsclinical.com\/wp-content\/uploads\/2024\/04\/fabry_disease.jpg?fit=828%2C420&ssl=1","width":828,"height":420,"caption":"Supporting patients with Fabry disease"},{"@type":"BreadcrumbList","@id":"https:\/\/colpittsclinical.com\/supporting-patients-with-fabry-disease-in-clinical-trials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/colpittsclinical.com\/"},{"@type":"ListItem","position":2,"name":"Supporting Patients with Fabry Disease in Clinical Trials"}]},{"@type":"WebSite","@id":"https:\/\/colpittsclinical.com\/#website","url":"https:\/\/colpittsclinical.com\/","name":"Colpitts Klinikai","description":"beteg-\u00f6sszek\u00f6ttet\u00e9s","publisher":{"@id":"https:\/\/colpittsclinical.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/colpittsclinical.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"hu"},{"@type":"Organization","@id":"https:\/\/colpittsclinical.com\/#organization","name":"Colpitts Klinikai","url":"https:\/\/colpittsclinical.com\/","logo":{"@type":"ImageObject","inLanguage":"hu","@id":"https:\/\/colpittsclinical.com\/#\/schema\/logo\/image\/","url":"https:\/\/colpittsclinical.com\/wp-content\/uploads\/2017\/10\/cc-logo-212-1.png","contentUrl":"https:\/\/colpittsclinical.com\/wp-content\/uploads\/2017\/10\/cc-logo-212-1.png","width":212,"height":48,"caption":"Colpitts Clinical"},"image":{"@id":"https:\/\/colpittsclinical.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ColpittsClinicalTrialTravel\/","https:\/\/www.linkedin.com\/company\/colpittsclinical\/"]},{"@type":"Person","@id":"https:\/\/colpittsclinical.com\/#\/schema\/person\/7f5c1f500aa2df676ac51a2c6236e2fd","name":"klinikai","image":{"@type":"ImageObject","inLanguage":"hu","@id":"https:\/\/secure.gravatar.com\/avatar\/b87dd30974d276d493a32a1592debd029f0e03dcf67fc5da941cf694874d67de?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b87dd30974d276d493a32a1592debd029f0e03dcf67fc5da941cf694874d67de?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b87dd30974d276d493a32a1592debd029f0e03dcf67fc5da941cf694874d67de?s=96&d=mm&r=g","caption":"clinical"},"url":"https:\/\/colpittsclinical.com\/hu\/author\/cclinical\/"}]}},"jetpack_featured_media_url":"https:\/\/i0.wp.com\/colpittsclinical.com\/wp-content\/uploads\/2024\/04\/fabry_disease.jpg?fit=828%2C420&ssl=1","jetpack_sharing_enabled":true,"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/colpittsclinical.com\/hu\/wp-json\/wp\/v2\/posts\/5116","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/colpittsclinical.com\/hu\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/colpittsclinical.com\/hu\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/colpittsclinical.com\/hu\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/colpittsclinical.com\/hu\/wp-json\/wp\/v2\/comments?post=5116"}],"version-history":[{"count":4,"href":"https:\/\/colpittsclinical.com\/hu\/wp-json\/wp\/v2\/posts\/5116\/revisions"}],"predecessor-version":[{"id":5122,"href":"https:\/\/colpittsclinical.com\/hu\/wp-json\/wp\/v2\/posts\/5116\/revisions\/5122"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/colpittsclinical.com\/hu\/wp-json\/wp\/v2\/media\/5132"}],"wp:attachment":[{"href":"https:\/\/colpittsclinical.com\/hu\/wp-json\/wp\/v2\/media?parent=5116"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/colpittsclinical.com\/hu\/wp-json\/wp\/v2\/categories?post=5116"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/colpittsclinical.com\/hu\/wp-json\/wp\/v2\/tags?post=5116"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}